Correlación entre la atenuación hepática y el compromiso pulmonar de los pacientes con COVID-19: Revisión narrativa

Abstract

Abstract: Introduction: Studies during the pandemic have shown a high degree of hepatic steatosis in patients with COVID-19, which in turn leads to a higher risk of complications. Computed tomography (CT) is the cornerstone as an immediate diagnostic method for the approach of patients with COVID-19, and, in addition, an effective tool for the diagnosis of fatty liver, so the initial images could establish a relationship between the degree of non-alcoholic hepatic steatosis and the adverse clinical course of patients with COVID-19.Objective: To review the literature that relates hepatic steatosis and pulmonary involvement in patients with COVID-19.Methodology: A search was carried out in the following databases: Pubmed, Cochrane, Scopus andScience Direct, using keywords and limiters.Conclusion: the literature published so far has shown that there is a significant prevalence of steatosis in patients with COVID-19, suggesting this as a risk factor for complications, for which the timely identification, through chest CT, could provide information on the course of the disease.